Cell Transfection Tip Assembly with Constriction for High Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for introducing genetic material into cells, such as electroporation and viral vectors, face limitations including low efficiency, toxicity, and cell viability issues, particularly for difficult-to-transfect cell types like stem cells and nerve cells, requiring a more efficient and universal approach.

Innovation Solution

A tip assembly with a constriction portion that generates increased fluid velocity and decreased pressure, creating membrane pores for efficient introduction of genetic material into cells, using a combination of a channel and constriction portion with specific geometries and materials, including glass, metal, or polymer, to enhance cell membrane pore formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If electroporation or viral vectors are used to introduce genetic material into cells, then genetic material can be delivered into the cell nucleus or cytoplasm, but transfection efficiency is low and cell viability is reduced

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidcell toxicity and cell death
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent replaces mechanical methods (electroporation, microinjection) and chemical methods (viral vectors, lipofection) with a fluid dynamic system. Cells are suspended in fluid and passed through a constriction portion at controlled flow rates, using fluid pressure and velocity to facilitate genetic material uptake without mechanical puncture or chemical toxicity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent controls transfection efficiency by adjusting fluid flow parameters including flow rate, pressure differential, and constriction geometry. By varying these parameters, the system optimizes the balance between genetic material delivery efficiency and cell viability, achieving high transfection without the toxicity of conventional methods.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If conventional transfection methods are used, then some genetic material is introduced into cells, but the method is not effective for difficult-to-transfect cell types such as stem cells, nerve cells, and muscle cells

Engineering Contradiction:
Improveapplicability to different cell typesVSAvoidtransfection efficiency
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent creates a universal transfection system that works across diverse cell types including stem cells, nerve cells, muscle cells, and primary cells. The fluid dynamic approach through the constriction portion provides a mechanism that overcomes the membrane barriers of difficult-to-transfect cells without requiring cell-type-specific optimization, achieving broad applicability and high efficiency simultaneously.

Inventive Principle:
Principle #6Universality (Multi-functionality)

3Productivity

If high pressure is applied to introduce genetic material into cells, then transfection efficiency increases, but cell injury and death increase

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidcell injury
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The patent applies pressure differentially: high pressure is applied only at the constriction portion where cells pass through, while the rest of the cell suspension remains at lower pressure. This localized high-pressure application facilitates genetic material uptake at the critical interface without subjecting the entire cell population to damaging high-pressure conditions, thereby maintaining cell viability.

Inventive Principle:
Principle #3Local quality

4Reliability

If viral vectors are used for transfection, then genetic material can be introduced into cells, but the process is time-consuming and requires biohazard level 2 conditions

Engineering Contradiction:
Improvetransfection efficiencyVSAvoidtime delay for protein expression
Core Design Contradiction:
ReliabilityVSLoss of time

Solution Approach 1:

The patent replaces biological viral vectors with a purely physical fluid dynamic system. This eliminates the time delay associated with viral infection and protein expression, allowing direct introduction of genetic material into cells. The system also eliminates the need for biohazard level 2 conditions, enabling faster, safer transfection procedures.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method achieves high transfection efficiency and cell viability, allowing for rapid protein expression in various cell types, including those previously difficult to transfect, without the need for viruses or toxic chemicals, and is applicable to both living and non-viable cells.

Implementation Method 1

such that increased fluid velocity and a decreased pressure in the fluid in the constriction portion compared to velocity and pressure in the channel portion enhances formation of membrane pores in the cells

Methodology Applied
Scientific EffectFluid velocity increase and pressure decrease in constriction portion: Bernoulli Effect

Implementation Method 2

a flow device that generates at least one of a positive pressure and a negative pressure for impelling or directing the fluid

Methodology Applied
Scientific EffectPressure generation: Pressure Increase

Data Source

PatentUS11473107B2Methods, tip assemblies and kits for introducing material into cells
Publication Date: 2022.10.18 TUFTS UNIV
  • US11473107B2 patent drawing
  • US11473107B2 patent drawing
  • US11473107B2 patent drawing

AI summary

Methods, tip assemblies and kits are provided for introducing material into cells. The tip assemblies include an attachment portion, a channel portion, and a constriction that function to reduce fluid pressure as a fluid passes through the constriction portion from the channel portion, whereby the tip assemblies form pores in the membranes of cells and introduce material into the cells. The material includes for example one selected from the group of: an inorganic compound, a drug, a genetic material, a protein, a carbohydrate, a synthetic polymer, and a pharmaceutical composition.